Luca G. Guidotti
Università Vita-Salute San Raffaele
H-index: 76
Europe-Italy
Top articles of Luca G. Guidotti
Title | Journal | Author(s) | Publication Date |
|---|---|---|---|
Agents and Methods for Increasing Liver Immune Response | 2024/1/4 | ||
Antibody-independent protection against heterologous SARS-CoV-2 challenge conferred by prior infection or vaccination | Nature Immunology | Valeria Fumagalli Micol Ravà Davide Marotta Pietro Di Lucia Elisa B Bono | 2024/3/14 |
Preclinical evaluation of therapeutic vaccines for chronic hepatitis B that stimulate antiviral activities of T cells and NKT cells | JHEP Reports | Anna H Mooney Sarah L Draper Olivia K Burn Regan J Anderson Benjamin J Compton | 2024/2/12 |
Spirocyclic inhibitors of hepatitis b virus | 2023/5/18 | ||
Nirmatrelvir treatment of SARS‐CoV‐2‐infected mice blunts antiviral adaptive immune responses | EMBO molecular medicine | Valeria Fumagalli Pietro Di Lucia Micol Ravà Davide Marotta Elisa Bono | 2023/5/8 |
Inhibitors of hepatitis b virus | 2023/3/9 | ||
Arenaviral infection causes bleeding in mice due to reduced serotonin release from platelets | Science Signaling | Roberto Aiolfi Giovanni Sitia Matteo Iannacone Ivan Brunetta Luca G Guidotti | 2022/2/22 |
Immunological insights in the treatment of chronic hepatitis B | Matteo Iannacone Francesco Andreata Luca G Guidotti | 2022/8/1 | |
Tricyclic inhibitors of Hepatitis B virus | 2022/11/22 | ||
COVID-eVax, an electroporated DNA vaccine candidate encoding the SARS-CoV-2 RBD, elicits protective responses in animal models | Molecular Therapy | Antonella Conforti Emanuele Marra Fabio Palombo Giuseppe Roscilli Micol Ravà | 2022/1/5 |
Low‐dose aspirin reduces the risk of HBV‐associated HCC even when administered short‐term: Too good to be true? | Hepatology | Luca G Guidotti Carlo La Vecchia Massimo Colombo | 2022/8/1 |
Continuous sensing of IFNα by hepatic endothelial cells shapes a vascular antimetastatic barrier | Elife | Ngoc Lan Tran Lorena Maria Ferreira Blanca Alvarez-Moya Valentina Buttiglione Barbara Ferrini | 2022/10/25 |
Immunobiology and pathogenesis of hepatitis B virus infection | Matteo Iannacone Luca G Guidotti | 2022/1 | |
Time to rethink lifelong therapies | Nature | Matteo Iannacone Luca G Guidotti | 2022/3/31 |
Discovery and antiviral profile of new sulfamoylbenzamide derivatives as HBV capsid assembly modulators | Bioorganic & Medicinal Chemistry Letters | Leda Ivanova Bencheva Lorena Donnici Luca Ferrante Adolfo Prandi Roberta Sinisi | 2022/10/1 |
Developing a cure for chronic hepatitis B requires a fresh approach. | nature | Matteo Iannacone Luca G Guidotti | 2022/3/1 |
Agents and Methods for Treating Viral Infections | 2022/8/11 | ||
Group 1 ILCs regulate T cell–mediated liver immunopathology by controlling local IL-2 availability | Science immunology | Valeria Fumagalli Valentina Venzin Pietro Di Lucia Federica Moalli Xenia Ficht | 2022/2/25 |
Oxalamido-substituted tricyclic inhibitors of hepatitis b virus | 2022/8/4 | ||
Nirmatrelvir treatment blunts the development of antiviral adaptive immune responses in SARS-CoV-2 infected mice | bioRxiv | Valeria Fumagalli Pietro Di Lucia Micol Ravà Davide Marotta Elisa Bono | 2022/11/22 |
Co-Authors
